Johnson & Johnson (NYSE:JNJ) Under Pressure on New Entrance- Silvercorp Metals (NYSE:SVM), Medtronic (NYSE:MDT), The Charles Schwab (NYSE:SCHW)
Johnson & Johnson (NYSE:JNJ) dropped around 2% in last session as Janssen Pharma declared that it will invest in a novel scientific approach, called disease interception, to find ways to ...